Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 1,137 shares at $6.03 ($7K) on 2024-09-20, disclosed to the SEC on 2024-09-24.
Open-market purchase of $7k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |
| SER | BUY | 2024-08-22 | $15K | — | Filing → |